Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Access to data in industry-sponsored trials.

Lundh A, Krogsbøll LT, Gøtzsche PC.

Lancet. 2011 Dec 10;378(9808):1995-6. doi: 10.1016/S0140-6736(11)61871-0. No abstract available.

PMID:
22153200
2.

Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.

Mansi BA, Clark J, David FS, Gesell TM, Glasser S, Gonzalez J, Haller DG, Laine C, Miller CL, Mooney LA, Zecevic M.

Mayo Clin Proc. 2012 May;87(5):424-9. doi: 10.1016/j.mayocp.2012.02.009. No abstract available.

3.

Sponsors' participation in conduct and reporting of industry trials: a descriptive study.

Lundh A, Krogsbøll LT, Gøtzsche PC.

Trials. 2012 Aug 24;13:146. doi: 10.1186/1745-6215-13-146.

4.

Data sharing, year 1--access to data from industry-sponsored clinical trials.

Strom BL, Buyse M, Hughes J, Knoppers BM.

N Engl J Med. 2014 Nov 27;371(22):2052-4. doi: 10.1056/NEJMp1411794. No abstract available.

5.

[Insufficient access to research data not acceptable].

Jørgensen AW, Gøtzsche PC.

Ugeskr Laeger. 2010 May 24;172(21):1585. Danish. No abstract available.

PMID:
20525470
6.

Sharing of Data From Industry-Funded Registered Clinical Trials.

Boutron I, Dechartres A, Baron G, Li J, Ravaud P.

JAMA. 2016 Jun 28;315(24):2729-30. doi: 10.1001/jama.2016.6310. No abstract available.

PMID:
27367768
8.

Regulation of clinical research sponsored by pharmaceutical companies: a proposal.

Sotelo J.

PLoS Med. 2006 Jul;3(7):e306. No abstract available.

9.

What constitutes full access to data in industry-funded trials?

[No authors listed]

Lancet. 2011 Dec 10;378(9808):1976. doi: 10.1016/S0140-6736(11)61859-X. No abstract available.

PMID:
22153190
10.

Data availability for industry sponsored trials: what should medical journals require?

Steinbrook R, Kassirer JP.

BMJ. 2010 Oct 12;341:c5391. doi: 10.1136/bmj.c5391. No abstract available.

PMID:
20940213
11.

Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.

Matcham J, Julious S, Pyke S, O'Kelly M, Todd S, Seldrup J, Day S.

Pharm Stat. 2011 Jan-Feb;10(1):70-3. doi: 10.1002/pst.417.

PMID:
20187020
12.

How skeptical should we be about industry-sponsored studies?

Meador KJ.

Neurology. 2007 Apr 10;68(15):1238; author reply 1238. No abstract available.

PMID:
17420417
13.

Trust in the medical literature--and Viewpoints in JAMA Internal Medicine.

Steinbrook R, Redberg RF.

JAMA Intern Med. 2013 Jun 24;173(12):1047-8. doi: 10.1001/jamainternmed.2013.6281. No abstract available.

PMID:
23609117
14.

Pharmaceutical company-sponsored drug trials: what are we to believe?

Shekelle P.

J Clin Epidemiol. 2010 Feb;63(2):126-7. doi: 10.1016/j.jclinepi.2009.07.014. No abstract available.

PMID:
19836207
15.

Making available information from studies sponsored by the pharmaceutical industry: some current practices.

O'Kelly M, Julious SA, Pyke S, Day S, Todd S, Seldrup J, Matcham J.

Pharm Stat. 2011 Jan-Feb;10(1):60-9. doi: 10.1002/pst.430.

PMID:
21275036
16.

Pharmaceutical company-sponsored drug trials: the system is broken.

Gartlehner G, Fleg A.

J Clin Epidemiol. 2010 Feb;63(2):128-9. doi: 10.1016/j.jclinepi.2009.07.015. No abstract available.

PMID:
19880288
17.

Are results from pharmaceutical-company-sponsored studies available to the public?

Dal-Ré R, Pedromingo A, García-Losa M, Lahuerta J, Ortega R.

Eur J Clin Pharmacol. 2010 Nov;66(11):1081-9. doi: 10.1007/s00228-010-0898-y. Erratum in: Eur J Clin Pharmacol. 2011 Jun;67(6):643.

PMID:
20844869
18.

Commenting on ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research.

Stossel TP, Stell LK.

Mayo Clin Proc. 2012 Sep;87(9):925-6; author reply 926. doi: 10.1016/j.mayocp.2012.06.020. No abstract available.

19.

Commentary: But what should journals actually do to keep industry sponsored research unbiased?

Del Mar C.

BMJ. 2010 Oct 12;341:c5406. doi: 10.1136/bmj.c5406. No abstract available.

PMID:
20940215
20.

JAMA's policy on industry sponsored studies.

Fontanarosa PB, DeAngelis CD.

BMJ. 2006 Jan 21;332(7534):177. No abstract available.

Supplemental Content

Support Center